JPI Healthcare

0010V0 · KOSDAQ · Health Care · SMALL CAP

Provisional Q4 2025 results.

JPI Healthcare filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$8.51M (−3.6% year on year), operating profit of US$989K (−21.9% year on year) and net income of US$1.18M (−34.5% year on year).

Earnings(Operating results (consolidated) (preliminary) (fair disclosure))· FILED 2026-02-23· RCEPT 20260223900382

US$8.51MRevenue
−3.6%Revenue vs a year earlier
US$989KOperating profit

Converted at 1 USD ≈ ₩1,443.44 (filing-date rate, 2026-02-23 close)

What happened

JPI Healthcare filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$8.51M (−3.6% year on year), operating profit of US$989K (−21.9% year on year) and net income of US$1.18M (−34.5% year on year).

These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.

RevenueUS$8.51M
Revenue vs a year earlier−3.6%
Operating profitUS$989K
Net incomeUS$1.18M
PeriodQ4 2025 (consolidated)
Filed2026-02-23, Operating results (consolidated) (preliminary) (fair disclosure)
SourceDART rcept 20260223900382 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-02-23 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.